Topic
Johnson & Johnson
Johnson & Johnson Q3 Earnings Surpass Estimates
Johnson & Johnson beat third-quarter adjusted earnings estimates despite a significant drop in net profit driven by a multi-billion-dollar talc litigation charge.
Johnson & Johnson offers $5.5bn to settle US baby powder lawsuits
Johnson & Johnson has proposed a $5.5bn settlement to resolve tens of thousands of US lawsuits alleging its talc-based baby powder caused ovarian cancer.
Johnson & Johnson agrees $5.5bn settlement to resolve talc cancer lawsuits
Johnson & Johnson announced an estimated $5.5 billion settlement to resolve tens of thousands of lawsuits alleging its talc-based baby powder caused ovarian cancer.